Please enable JavaScript to continue using this application.

Compare $WAT vs $WST | Chartloom

Compare

$WAT vs $WST

Waters Corp · West Pharmaceutical Services Inc

WAT

Waters Corp

WST

West Pharmaceutical Services Inc

Compare $WAT vs $WST

Comparing Waters Corp and West Pharmaceutical Services Inc

WATWaters Corp

WSTWest Pharmaceutical Services Inc

WATWaters Corp

Market cap

$42.59B

P/E (TTM)

256.40x

Forward P/E (NTM)

26.79x

Forward P/S (NTM)

6.04x

Rev growth (TTM)

52.5%

YTD performance

13.6%

52W performance

32.4%

FCF yield

0.9%

WSTWest Pharmaceutical Services Inc

Market cap

$25.76B

P/E (TTM)

46.20x

Forward P/E (NTM)

39.00x

Forward P/S (NTM)

7.45x

Rev growth (TTM)

12.4%

YTD performance

32.4%

52W performance

36.6%

FCF yield

1.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

WAT

WST

Detailed metrics comparison

WAT

Waters Corp

WST

West Pharmaceutical Services Inc

Market Cap

WAT$42.59B

WST$25.76B

Enterprise Value

WAT$47.14B

WST$25.53B

Price

WAT$433.77

WST$366.00

P/E Ratio

WAT256.40x

WST46.20x

P/S Ratio

WAT9.17x

WST7.74x

EV/Sales

WAT10.15x

WST7.67x

EV/EBITDA

WAT36.21x

WST28.16x

P/B Ratio

WAT2.83x

WST8.84x

P/FCF Ratio

WAT106.89x

WST58.96x

EV/FCF

WAT118.31x

WST58.44x

PEG Ratio

WATN/A

WST3.05x

Forward P/E (NTM)

WAT26.79x

WST39.00x

Forward P/S (NTM)

WAT6.04x

WST7.45x

Revenue (TTM)

WAT$4.64B

WST$3.33B

Revenue Growth (YoY)

WAT52.5%

WST12.4%

Forward Rev Growth

WAT10.4%

WST6.2%

Gross Margin (TTM)

WAT50.9%

WST36.8%

Operating Margin (TTM)

WAT7.1%

WST20.4%

EBITDA Margin (TTM)

WAT28.0%

WST27.0%

Net Margin (TTM)

WAT3.6%

WST17.0%

FCF Margin (TTM)

WAT8.6%

WST13.1%

Net Income (TTM)

WAT$166M

WST$565M

FCF (TTM)

WAT$398M

WST$437M

EPS (TTM)

WAT$1.69

WST$7.92

ROE (TTM)

WAT1.9%

WST18.5%

ROA (TTM)

WAT1.1%

WST13.6%

ROIC (TTM)

WAT1.4%

WST17.3%

Cash

WAT$539M

WST$436M

Debt

WAT$5.09B

WST$207M

Net Cash/Debt

WAT$-4.55B

WST$229M

Current Ratio (TTM)

WAT1.79x

WST2.82x

Quick Ratio (TTM)

WAT1.13x

WST2.12x

Debt/Equity (TTM)

WAT0.33x

WST0.07x

Debt/Assets (TTM)

WAT0.0%

WST0.0%

Interest Coverage (TTM)

WATN/A

WSTN/A

Net Debt/EBITDA (TTM)

WAT0.00x

WST0.00x

Beta

WAT1.16

WST1.15

52W Performance

WAT32.4%

WST36.6%

YTD Performance

WAT13.6%

WST32.4%

% from 52W High

WAT-4.6%

WST-5.2%

% from 52W Low

WAT53.4%

WST63.5%

Asset Turnover (TTM)

WAT0.31x

WST0.80x

FCF Yield (TTM)

WAT0.9%

WST1.7%

Earnings Yield (TTM)

WAT0.4%

WST2.2%

Dividend Yield (TTM)

WATN/A

WST0.2%

Rule of 40

WAT61.0

WST25.5

EV/GP/RG

WAT0.38

WST5.32

Ticker research

View WAT research View WST research

Metric	WAT Waters Corp	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$42.59B	$25.76B
Enterprise Value	$47.14B	$25.53B
Price	$433.77	$366.00
P/E Ratio	256.40x	46.20x
P/S Ratio	9.17x	7.74x
EV/Sales	10.15x	7.67x
EV/EBITDA	36.21x	28.16x
P/B Ratio	2.83x	8.84x
P/FCF Ratio	106.89x	58.96x
EV/FCF	118.31x	58.44x
PEG Ratio	N/A	3.05x
Forward P/E (NTM)	26.79x	39.00x
Forward P/S (NTM)	6.04x	7.45x
Revenue & Growth
Revenue (TTM)	$4.64B	$3.33B
Revenue Growth (YoY)	52.5%	12.4%
Forward Rev Growth	10.4%	6.2%
Profitability
Gross Margin (TTM)	50.9%	36.8%
Operating Margin (TTM)	7.1%	20.4%
EBITDA Margin (TTM)	28.0%	27.0%
Net Margin (TTM)	3.6%	17.0%
FCF Margin (TTM)	8.6%	13.1%
Net Income (TTM)	$166M	$565M
FCF (TTM)	$398M	$437M
EPS (TTM)	$1.69	$7.92
ROE (TTM)	1.9%	18.5%
ROA (TTM)	1.1%	13.6%
ROIC (TTM)	1.4%	17.3%
Financial Health
Cash	$539M	$436M
Debt	$5.09B	$207M
Net Cash/Debt	$-4.55B	$229M
Current Ratio (TTM)	1.79x	2.82x
Quick Ratio (TTM)	1.13x	2.12x
Debt/Equity (TTM)	0.33x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.16	1.15
52W Performance	32.4%	36.6%
YTD Performance	13.6%	32.4%
% from 52W High	-4.6%	-5.2%
% from 52W Low	53.4%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.80x
FCF Yield (TTM)	0.9%	1.7%
Earnings Yield (TTM)	0.4%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	61.0	25.5
EV/GP/RG	0.38	5.32
Ticker research	View WAT research	View WST research

Valuation

P/E Ratio

WST

46.20x

WAT

256.40x

P/S Ratio

WST

7.74x

WAT

9.17x

EV/FCF

WST

58.44x

WAT

118.31x

Growth & revenue

Revenue Growth TTM

WAT

52.5%

WST

12.4%

Forward Revenue Growth

WAT

10.4%

WST

6.2%

Profitability & performance

Gross Margin

WAT

50.9%

WST

36.8%

ROE

WST

18.5%

WAT

1.9%

FCF Yield %

WST

1.7%

WAT

0.9%

52-Week Performance

WST

36.6%

WAT

32.4%

Detailed metrics comparison

WAT

Waters Corp

WST

West Pharmaceutical Services Inc

Market Cap

WAT$42.59B

WST$25.76B

Enterprise Value

WAT$47.14B

WST$25.53B

Price

WAT$433.77

WST$366.00

P/E Ratio

WAT256.40x

WST46.20x

P/S Ratio

WAT9.17x

WST7.74x

EV/Sales

WAT10.15x

WST7.67x

EV/EBITDA

WAT36.21x

WST28.16x

P/B Ratio

WAT2.83x

WST8.84x

P/FCF Ratio

WAT106.89x

WST58.96x

EV/FCF

WAT118.31x

WST58.44x

PEG Ratio

WATN/A

WST3.05x

Forward P/E (NTM)

WAT26.79x

WST39.00x

Forward P/S (NTM)

WAT6.04x

WST7.45x

Revenue (TTM)

WAT$4.64B

WST$3.33B

Revenue Growth (YoY)

WAT52.5%

WST12.4%

Forward Rev Growth

WAT10.4%

WST6.2%

Gross Margin (TTM)

WAT50.9%

WST36.8%

Operating Margin (TTM)

WAT7.1%

WST20.4%

EBITDA Margin (TTM)

WAT28.0%

WST27.0%

Net Margin (TTM)

WAT3.6%

WST17.0%

FCF Margin (TTM)

WAT8.6%

WST13.1%

Net Income (TTM)

WAT$166M

WST$565M

FCF (TTM)

WAT$398M

WST$437M

EPS (TTM)

WAT$1.69

WST$7.92

ROE (TTM)

WAT1.9%

WST18.5%

ROA (TTM)

WAT1.1%

WST13.6%

ROIC (TTM)

WAT1.4%

WST17.3%

Cash

WAT$539M

WST$436M

Debt

WAT$5.09B

WST$207M

Net Cash/Debt

WAT$-4.55B

WST$229M

Current Ratio (TTM)

WAT1.79x

WST2.82x

Quick Ratio (TTM)

WAT1.13x

WST2.12x

Debt/Equity (TTM)

WAT0.33x

WST0.07x

Debt/Assets (TTM)

WAT0.0%

WST0.0%

Interest Coverage (TTM)

WATN/A

WSTN/A

Net Debt/EBITDA (TTM)

WAT0.00x

WST0.00x

Beta

WAT1.16

WST1.15

52W Performance

WAT32.4%

WST36.6%

YTD Performance

WAT13.6%

WST32.4%

% from 52W High

WAT-4.6%

WST-5.2%

% from 52W Low

WAT53.4%

WST63.5%

Asset Turnover (TTM)

WAT0.31x

WST0.80x

FCF Yield (TTM)

WAT0.9%

WST1.7%

Earnings Yield (TTM)

WAT0.4%

WST2.2%

Dividend Yield (TTM)

WATN/A

WST0.2%

Rule of 40

WAT61.0

WST25.5

EV/GP/RG

WAT0.38

WST5.32

Ticker research

View WAT research View WST research

Metric	WAT Waters Corp	WST West Pharmaceutical Services Inc
Market & Valuation
Market Cap	$42.59B	$25.76B
Enterprise Value	$47.14B	$25.53B
Price	$433.77	$366.00
P/E Ratio	256.40x	46.20x
P/S Ratio	9.17x	7.74x
EV/Sales	10.15x	7.67x
EV/EBITDA	36.21x	28.16x
P/B Ratio	2.83x	8.84x
P/FCF Ratio	106.89x	58.96x
EV/FCF	118.31x	58.44x
PEG Ratio	N/A	3.05x
Forward P/E (NTM)	26.79x	39.00x
Forward P/S (NTM)	6.04x	7.45x
Revenue & Growth
Revenue (TTM)	$4.64B	$3.33B
Revenue Growth (YoY)	52.5%	12.4%
Forward Rev Growth	10.4%	6.2%
Profitability
Gross Margin (TTM)	50.9%	36.8%
Operating Margin (TTM)	7.1%	20.4%
EBITDA Margin (TTM)	28.0%	27.0%
Net Margin (TTM)	3.6%	17.0%
FCF Margin (TTM)	8.6%	13.1%
Net Income (TTM)	$166M	$565M
FCF (TTM)	$398M	$437M
EPS (TTM)	$1.69	$7.92
ROE (TTM)	1.9%	18.5%
ROA (TTM)	1.1%	13.6%
ROIC (TTM)	1.4%	17.3%
Financial Health
Cash	$539M	$436M
Debt	$5.09B	$207M
Net Cash/Debt	$-4.55B	$229M
Current Ratio (TTM)	1.79x	2.82x
Quick Ratio (TTM)	1.13x	2.12x
Debt/Equity (TTM)	0.33x	0.07x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.16	1.15
52W Performance	32.4%	36.6%
YTD Performance	13.6%	32.4%
% from 52W High	-4.6%	-5.2%
% from 52W Low	53.4%	63.5%
Efficiency & Yields
Asset Turnover (TTM)	0.31x	0.80x
FCF Yield (TTM)	0.9%	1.7%
Earnings Yield (TTM)	0.4%	2.2%
Dividend Yield (TTM)	N/A	0.2%
Other
Rule of 40	61.0	25.5
EV/GP/RG	0.38	5.32
Ticker research	View WAT research	View WST research